stocksbrew

Eli Lilly and CompanyLLY

Buy more

Buy more on a dip to our buy price, which is under Friday's $1,347.

  • 11 good· Earnings beat
  • 1 to watch· Pricier than rivals

$1,347.42−3.70 (−0.27%)

After hours $1,348.06 +0.1% · 7:59 PM ET on Friday

Price at 3:59 PM ET on Friday

Market closed · opens in 22h 24mNext open: Monday, Nov 23, 9:30 AM ET

NYSE · Healthcare · Drug Manufacturers - General · Very large company

The price we'd buy LLY at comes with a free account

It also has the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.

What would change it

Sources

Could move it to Keep

Next report

  • below23%

    sales growth

Compared with the S&P 500

  • 8 points

    worse in one day

  • 17 points

    worse in five trading days

+29.9% in a year

Earnings report

The news behind our call

written Friday, 4:18 PM ETFriday, 4:18 PM ET · 8 articles · 6 sources

How LLY's risks changed

10-K filed Feb 12 against its 10-K from Feb 19, 2025

5reworded

Read 5 more
Reworded
  • We and our products face intense competition, and such competition could have a material adverse effect on our business.Was: We and our products face intense competition, including from multinational pharmaceutical companies, biotechnology companies, and lower-cost generic and biosimilar manufacturers, and such competition could have a material adverse effect on our business.
  • Our business is subject to government price controls and other public and private restrictions on pricing, reimbursement, and access for our drugs, which could have a material adverse effect on our results of operations, reputation, or business.Was: Our business is subject to increasing government price controls and other public and private restrictions on pricing, reimbursement, and access for our drugs, which could have a material adverse effect on our results of operations, reputation or business.
  • Manufacturing, quality, or supply chain difficulties, disruptions, or shortages could lead to product supply problems or other negative outcomes.Was: Manufacturing, quality, or supply chain difficulties, disruptions, or shortages could lead to product supply problems.
  • Our global operations subject us to risks, including as related to uneven economic growth or downturns, international trade, and other global disruptions, geopolitical tensions, or disputes.Was: Uneven economic growth or downturns or international trade and other global disruptions, geopolitical tensions, or disputes could adversely affect our business and operating results.
  • We are party to litigation and investigations, which could adversely affect our business.Was: We are party to litigation and investigations related to our products, how we price or commercialize our products, and other aspects of our business, which could adversely affect our business, and we are self-insured for such matters.

What changed

  1. This month
  2. Analyst ratings shifted: 1 fewer buy, 1 more hold

    Analysts

  3. Yesterday
  4. Eli Lilly’s next Weight-Loss Drug Helped Patients Lose up to 54 Pounds. Why the FDA’s new warning Didn’t Hurt LLY stock.

  5. Friday
  6. Eli Lilly after ObesityWeek is the stock still undervalued

  7. What does Eli Lilly Offer that Merck does not?

  8. Lilly vs. Pfizer: Which Drugmaker has stronger growth Prospects?

  9. ETFs are net sellers of Eli Lilly on Nov. 18

  10. Thursday
  11. Jefferies has Wall Street’s Highest target on Eli Lilly. Why?

  12. Eli Lilly – the only Healthcare Name in Ken Fisher’s Fastest-Growing top positions

Overview

Key figures

Revenue (TTM)
$86.5B
Revenue growth, 1 year
+45.5%
Net income
$27.6B
EPS (diluted)
$30.81
Gross margin
83.6%
Operating margin
51.3%
Return on equity
86.0%
Return on capital
42.7%
Debt / equity
1.23
Current ratio
1.39
Dividend yield
0.51%
Buyback yield
0.58%

Revenue by region

period ending Sep 30, 2026
  • United States$56.1B · 64%
  • Europe$15.3B · 17%
  • Rest of World$11.0B · 13%
  • China$3.0B · 3.5%
  • Japan$2.5B · 2.8%

Key facts

Company value
$1.27T
Price / last year's earnings
43.7×
Today's range
1341.771372.05
Past year's range
847.501443.50
Yesterday's close
$1,351.12
Swings vs the market
0.5×smaller
Dividend yield
0.51%$6.92 a year

Compare LLY with

Weekend

Still Sunday. Nothing's moving except the clock.

22hrs24min18sec

Market opens Monday, Nov 23 at 9:30 AM ET